Gordon Mikael 4
4 · HAEMONETICS CORP · Filed May 7, 2012
Insider Transaction Report
Form 4
Gordon Mikael
President, Haemonetics Europe
Transactions
- Exercise/Conversion
Common Stock
2012-05-03$55.14/sh+8,000$441,120→ 12,442 total - Sale
Common Stock
2012-05-03$71.50/sh−8,000$571,987→ 4,442 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-03$71.50/sh−8,000$571,987→ 0 totalExercise: $55.14From: 2009-01-22Exp: 2015-01-22→ Common Stock (8,000 underlying)
Holdings
- 3,812
Non-Qualified Stock Option (right to buy)
Exercise: $54.55From: 2009-10-22Exp: 2015-10-22→ Common Stock (3,812 underlying) - 14,205
Non-Qualified Stock Option (right to buy)
Exercise: $54.99From: 2011-10-27Exp: 2017-10-27→ Common Stock (14,205 underlying) - 17,565
Non-Qualified Stock Option (right to buy)
Exercise: $61.34From: 2012-10-25Exp: 2018-10-25→ Common Stock (17,565 underlying) - 9,794
Non-Qualified Stock Option (right to buy)
Exercise: $52.94From: 2010-10-27Exp: 2016-10-27→ Common Stock (9,794 underlying)
Footnotes (2)
- [F1]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.